Mariner
DERM icon

Mariner’s Journey Medical DERM Stock Holding History

Mariner’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.5K Buy
+13,348
New +$76.2K ﹤0.01% 3339

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Mariner's DERM Position: Q2 2026 in Review

Mariner opened a new position in Journey Medical (DERM) in Q2 2026: 13,348 shares worth $94.5K. The stake represents ﹤0.01% of the portfolio and ranks #3339 among its holdings.

71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Mariner held 13,348 shares of Journey Medical worth $94.5K as of Q2 2026.
  • Journey Medical was a new Mariner position in Q2 2026.
  • Journey Medical made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3339 holding.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.